Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "ECG"

42 News Found

Kauvery Hospital conducts 4th edition of ECG Masterclass 2026; 400+ medical professionals attend
Hospitals | April 14, 2026

Kauvery Hospital conducts 4th edition of ECG Masterclass 2026; 400+ medical professionals attend

Workshop on ECG interpretation also marks launch of “Handbook on ECGs – Volume 2”


Philips introduces at-home, 12-lead ECG integrated solution for trials
Medical Device | January 26, 2022

Philips introduces at-home, 12-lead ECG integrated solution for trials

Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials


Zeto gains FDA nod for new outpatient EEG system promising faster brain health testing
News | April 10, 2026

Zeto gains FDA nod for new outpatient EEG system promising faster brain health testing

The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE


Lupin Foundation expands NCD care access in Rajasthan with new diagnostic corners
News | April 10, 2026

Lupin Foundation expands NCD care access in Rajasthan with new diagnostic corners

The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure


Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial
Biotech | April 06, 2026

Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial

Safety was equally impressive. ENV-294 was well tolerated


Bioxytran reports 90% day-5 viral clearance in COVID-19 trial at highest dose of ProLectin-M
Clinical Trials | March 03, 2026

Bioxytran reports 90% day-5 viral clearance in COVID-19 trial at highest dose of ProLectin-M

Our clinical data suggests ProLectin-M demonstrated earlier reductions in viral shedding compared with placebo with a favorable safety profile


Ascletis reports positive phase Ib results for oral GLP-1R agonist ASC30 at EASD 2025
Clinical Trials | September 19, 2025

Ascletis reports positive phase Ib results for oral GLP-1R agonist ASC30 at EASD 2025

The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States


Ascletis' ASC30 obesity drug shows 75-day half-life in US Study
Clinical Trials | September 16, 2025

Ascletis' ASC30 obesity drug shows 75-day half-life in US Study

Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity


USV’s ‘United for BP Control’ Mission takes aim at India’s blood pressure epidemic
Healthcare | May 29, 2025

USV’s ‘United for BP Control’ Mission takes aim at India’s blood pressure epidemic

The initiative was announced at World Hypertension Congress, Chennai